Role of the renin-angiotensin system in vascular diseases: Expanding the field

Hypertension

Volumn 38, Issue 6, 2001, Pages 1382-1387

  Ruiz Ortega, M ^a,c   Lorenzo, O ^a   Ruperez M ^a   Esteban, V ^a   Suzuki, Y ^a   Mezzano, S ^b   Plaza, J J ^d   Egido, J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^d NONE

Author keywords

Angiotensin II; Fibrosis; Inflammation; Renal damage; Vascular damage

Indexed keywords

ANGIOTENSIN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOTACTIC FACTOR; CYTOKINE; GROWTH FACTOR; MITOGENIC AGENT; TRANSCRIPTION FACTOR; VASOACTIVE AGENT;

APOPTOSIS; CELL PROLIFERATION; CHEMOTAXIS; CONFERENCE PAPER; HUMAN; INFLAMMATION; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

EID: 0035674967     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy1201.100589     Document Type: Conference Paper

References (65)

1. Vasoactive hormones and renal sclerosis
2. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases
3. Angiotensin II and renal fibrosis
4. Cytokine actions of angiotensin II
5. Proinflammatory actions of angiotensin II
6. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability
7. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease
8. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages
9. Regulation of matrix proteins and impact on vascular structure
10. Effects of angiotensin converting enzyme inhibitor ramipril on cardiovascular events in high risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
11. Atherosclerosis: An inflammatory disease
12. Angiotensin II increases monocyte binding to endothelial cells
13. Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo
14. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin
15. Angiotensin II, and bradykinin regulate the expression of P-selectin on the surface of endothelial cells in culture
16. Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo
17. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis
18. 2 receptor-mediated P-selectin unregulation
19. Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis
20. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADP/NADPH oxidase activation: Contributions to alterations of vasomotor tone
21. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND (Trial on Reversing Endothelial Dysfunction) Study
22. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats
23. Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?
24. Biomechanical strain induces class a scavenger receptor expression in human monocyte/macrophages and THP-1 cells: A potential mechanism of increased atherosclerosis in hypertension
25. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice
26. Angiotensin converting enzyme inhibition prevents arterial NF-κB activation, MCP-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis
27. Angiotensin II participates in mononuclear cell recruitment in the kidney through nuclear factor-κB activation and monocyte chemoattractant protein-1 gene expression
28. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells
29. ACE inhibitor quinapril reduces the arterial expression of NF-κB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis
30. Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells
31. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-κB transcription factors
32. 2-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells
33. -/- mice reveals a role for chemokines in the initiation of atherosclerosis
34. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II induced hypertension
35. Angiotensin II-stimulated vascular remodeling: The search for the culprit oxidase
36. Angiotensin II stimulates NADH and NADPH oxidase activation in cultured vascular smooth muscle cells
37. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice
38. Novel gp91phox homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways
39. Angiotensin induces inflammatory activation of human vascular smooth muscle cells
40. Angiotensin and atherosclerosis
41. 2 receptors in the kidney
42. 1 knockout mice
43. 2 receptors in cultured vascular smooth muscle cells. Molecular mechanisms
44. 2 receptors
45. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells: Role of the angiotensin type 2 receptor
46. The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
47. 1 knockout mice with unilateral ureteral obstruction
48. 1 receptor inhibition on chemoattractant and adhesion molecule synthesis
49. Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes
50. Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-κB (NF-κB) transcription factor
51. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide
52. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
53. Modulation of parathyroid hormone (PTH)-related protein (PTHrP) system by angiotensin II in the rat kidney
54. Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis
55. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions
56. Angiotensin II increases connective tissue growth factor in vascular smooth muscle cells
57. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo
58. Synthesis and effects of active fragments of angiotensin II
59. Angiotensin III is a new chemoattractant for polymorphonuclear leukocytes
60. Angiotensin III increases MCP-1 and activates NF-κB and AP-1 in cultured mesangial and mononuclear cells
61. Renin angiotensin system and renal damage: Emerging data on angiotensin II as a proinflammatory mediator
62. Angiotensin III upregulates genes involved in kidney damage in cultured mesangial cells and renal interstitial fibroblast
63. 4 receptor levels in carotid arteries following balloon injury
64. Angiotensin IV stimulates the proliferation of rat anterior pituitary cells in vitro
65. Angiotensin IV elicits a proinflammatory phenotype in vascular smooth muscle cells